Trial ID or NCT#

NCT02881151

Status

RECRUITING

Purpose

This study involves the treatment of cognitive impairment secondary to moderate to severe brain injury using central thalamic deep brain stimulation. Although all patients will receive stimulation continuously through a surgically implanted pacemaker-like device, half of the patients will have the device deactivated during a blinded assessment phase. The device will be reactivated following this assessment and patients will have the option to continue stimulation in an open-label continuation.

Official Title

CT-DBS for Traumatic Brain Injury Using the Medtronic Activa PC+S System

Eligibility Criteria

Ages Eligible for Study: 22 Years to 60 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Jaimie Henderson, MD
Functional neurosurgeon, Epilepsy neurosurgeon, Pain neurosurgeon, Movement disorders specialist, Deep brain stimulation specialist
John and Jene Blume - Robert and Ruth Halperin Professor, Professor of Neurosurgery and, by courtesy, of Neurology at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Jaimie M Henderson, MD
(650) 723-5574